c-Rel Is a Target of Pentoxifylline-Mediated Inhibition of T Lymphocyte Activation
- 28 February 1997
- journal article
- Published by Elsevier BV in Immunity
- Vol. 6 (2), 165-174
- https://doi.org/10.1016/s1074-7613(00)80423-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Transcriptional Regulation of the Interleukin-2 Gene in Normal Human Peripheral Blood T CellsJournal of Biological Chemistry, 1996
- Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.JCI Insight, 1995
- Oxpentifylline inhibits tumor necrosis factor‐α mRNA transcription and protects against arthritis in mercuric chloride‐treated Brown Norway ratsEuropean Journal of Immunology, 1995
- Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.Genes & Development, 1995
- Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles.The Journal of Experimental Medicine, 1994
- Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin ANature, 1991
- Regulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28Science, 1991
- Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell ActivationScience, 1989
- Functionally Distinct NF-κB Binding Sites in the Immunoglobulin κ and IL-2 Receptor α Chain GenesScience, 1989